Table 2.
Sample | Chr | Start | End | Gene | SNV INDEL |
SNP quality |
Protein change | Causative variant? |
In HGMD public? |
In dbSNP132 (1 %)? |
Polyphen-2 | sift | Mutation Assessor |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
47, XXY KS | chr10 | 104586872 | 104586873 | CYP17A1 | T→G | 34 | H79P | – | N | N | Possibly damaging |
Tolerated | Low |
47, XXY KS | chr8 | 106870217 | 106870218 | ZFPM2 | G→C | 114 | S210T | – | N | N | Benign | Tolerated | Neutral |
DSDPtl | chr2 | 31607980 | 31607981 | SRD5A2 | C→T | 225 | E200K | Y | Y | N | – | – | Medium |
DSDPt3 | chr8 | 11651992 | 11651993 | GATA4 | G→A | 228 | V380M | – | N | rs114868912 | Benign | Tolerated | Neutral |
DSDPt3 | chr9 | 1046731 | 1046732 | DMRT2 | G→A | 194 | R382Q | – | N | rs72703237 | Benign | Tolerated | Neutral |
DSDPt3 | chr17 | 75373191 | 75373192 | CBX2 | C→T | 228 | A452V | – | N | rs76915888 | Benign | Tolerated | Neutral |
DSDPt3 | chr9 | 1046397 | 1046398 | DMRT2 | C→G | 100 | P271A | – | N | rs72703236 | Probably damaging |
Damaging | Medium |
DSDPt3 | chrY | 2715264 | 2715265 | SRY | T→C | 225 | Y127C | Y | Y | N | Probably damaging |
– | – |
DSDPt5 | chr12 | 52104848 | 52104849 | AMHR2 | A→C | 136 | T108P | – | N | N | Possibly damaging |
Tolerated | Neutral |
DSDPt5 | chr8 | 106870217 | 106870218 | ZFPM2 | G→C | 228 | S210T | – | N | N | Benign | Tolerated | Neutral |
DSDPt6 | chr17 | 75373191 | 75373192 | CBX2 | C→T | 228 | A452V | – | N | rs76915888 | Benign | Tolerated | Neutral |
DSDPt6 | chrX | 139414764 | 139414765 | S0X3 | C→T | 228 | A43T | – | N | N | Benign | – | Neutral |
DSDPt7 | chrX | 66858443 | 66858444 | AR | T→C | 225 | M788T | Y | Y | N | Probably damaging |
Damaging | Medium |
DSDPt8 | chrX | 30237128 | 30237129 | NR0B1 | G→T | 212 | Y121 * | Y | Y | N | Termination | Termination | Termination |
DSDPt9 | chr9 | 884196 | 884197 | DMRT1 | T→G | 46 | V→Gb | – | N | rs116766038 | Non-coding by CCDS |
Non-coding by CCDS |
Non-coding by CCDS |
DSDPt9 | chr15 | 72424436 | 72424437 | CYP11A1 | INS:→A | 208 | Intronic splice-site mutation |
Y | N | N | INDELc | INDEL | INDEL |
DSDPt9 | chr15 | 72422525 | 72422526 | CYP11A1 | DEL:T→- | 726 | Frameshift, early-termination |
Y | Y | N | INDEL | INDEL | INDEL |
DSDPtl 1 | chr15 | 72446744 | 72446745 | CYP11A1 | C→T | 204 | V79I | – | N | N | Benign | Tolerated | Low |
DSDPtl 2 | chrX | 76824270 | 76824271 | ATRX | T→C | 139 | K1045E | Y | N | N | Probably damaging |
Tolerated | Low |
CCDS, consensus coding sequence; DSD, disorders of sex development; HGMD, Human Gene Mutation Database; INDELs, insertions and deletions; N, no; SNV, single-nucleotide variant; Y, yes.
High-quality SNVs with coding consequences identified in the 16 patients were run through a series of filters such as HGMD to identify SNVs and INDELs previously reported in the literature. All INDELs were reported as causative. Remaining SNVs were filtered using dbSNP132 (≥1% frequency) to identify rare variants. The identified rare SNV variants were then run through multiple in silico protein pathogenicity predictors to determining whether the coding variation was likely to be causative of the disease. Two of three pathogenicity predictors were required to indicate the mutation was ‘damaging’ in order for it to be classified as causative.
This mutation lies in the coding region of an isoform of DMRT1.
In silico protein predictors do not provide pathogenicity for INDELs.